147 related articles for article (PubMed ID: 19812382)
1. Genetic variation in CXCR4 and risk of chronic lymphocytic leukemia.
Crowther-Swanepoel D; Qureshi M; Dyer MJ; Matutes E; Dearden C; Catovsky D; Houlston RS
Blood; 2009 Nov; 114(23):4843-6. PubMed ID: 19812382
[TBL] [Abstract][Full Text] [Related]
2. ATM mutations are rare in familial chronic lymphocytic leukemia.
Yuille MR; Condie A; Hudson CD; Bradshaw PS; Stone EM; Matutes E; Catovsky D; Houlston RS
Blood; 2002 Jul; 100(2):603-9. PubMed ID: 12091354
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 overexpression in chronic lymphocytic leukemia associates with poorer prognosis: A prospective, single-center, observational study.
Xue X; Wen Z; Zhang X; Yang Y; Li Y; Liao R; Zheng Q; Fu Y; Liu Y; Liao H
Genes Immun; 2024 Apr; 25(2):117-123. PubMed ID: 38366101
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation and risk of chronic lymphocytic leukaemia.
Crowther-Swanepoel D; Houlston RS
Semin Cancer Biol; 2010 Dec; 20(6):363-9. PubMed ID: 20833250
[TBL] [Abstract][Full Text] [Related]
5. CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.
Ganghammer S; Hutterer E; Hinterseer E; Brachtl G; Asslaber D; Krenn PW; Girbl T; Berghammer P; Geisberger R; Egle A; Zucchetto A; Kruschinski A; Gattei V; Chigaev A; Greil R; Hartmann TN
Oncotarget; 2015 May; 6(14):12048-60. PubMed ID: 25895128
[TBL] [Abstract][Full Text] [Related]
6. Familial chronic lymphocytic leukemia.
Goldin LR; Slager SL; Caporaso NE
Curr Opin Hematol; 2010 Jul; 17(4):350-5. PubMed ID: 20389242
[TBL] [Abstract][Full Text] [Related]
7. Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
Kashyap MK; Amaya-Chanaga CI; Kumar D; Simmons B; Huser N; Gu Y; Hallin M; Lindquist K; Yafawi R; Choi MY; Amine AA; Rassenti LZ; Zhang C; Liu SH; Smeal T; Fantin VR; Kipps TJ; Pernasetti F; Castro JE
J Hematol Oncol; 2017 May; 10(1):112. PubMed ID: 28526063
[TBL] [Abstract][Full Text] [Related]
8. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
[TBL] [Abstract][Full Text] [Related]
9. p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes.
Patrussi L; Capitani N; Cattaneo F; Manganaro N; Gamberucci A; Frezzato F; Martini V; Visentin A; Pelicci PG; D'Elios MM; Trentin L; Semenzato G; Baldari CT
Oncogene; 2018 Mar; 37(11):1534-1550. PubMed ID: 29326436
[TBL] [Abstract][Full Text] [Related]
10. The role of polymorphisms of stromal-derived factor-1 and CXC receptor 4 in acute myeloid leukemia and leukemia cell dissemination.
Zheng Q; Shuai X; Ye Y; Jin Y; Jiang N; Chen X; Su J
Gene; 2016 Aug; 588(2):103-8. PubMed ID: 27154815
[TBL] [Abstract][Full Text] [Related]
11. Germline mutations in RAD51, RAD51AP1, RAD51B, RAD51C,RAD51D, RAD52 and RAD54L do not contribute to familial chronic lymphocytic leukemia.
Sellick G; Fielding S; Qureshi M; Catovsky D; ; Houlston R
Leuk Lymphoma; 2008 Jan; 49(1):130-3. PubMed ID: 18203022
[TBL] [Abstract][Full Text] [Related]
12. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
[TBL] [Abstract][Full Text] [Related]
13. Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway.
Kashyap MK; Kumar D; Jones H; Amaya-Chanaga CI; Choi MY; Melo-Cardenas J; Ale-Ali A; Kuhne MR; Sabbatini P; Cohen LJ; Shelat SG; Rassenti LZ; Kipps TJ; Cardarelli PM; Castro JE
Oncotarget; 2016 Jan; 7(3):2809-22. PubMed ID: 26646452
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations in Dok1 do not predispose to chronic lymphocytic leukemia.
Sellick GS; Coleman RJ; Talaban RV; Fleischmann C; Rudd MF; Allinson R; Catovsky D; Houlston RS
Leuk Res; 2005 Jan; 29(1):59-61. PubMed ID: 15541476
[TBL] [Abstract][Full Text] [Related]
15. Inherited susceptibility to CLL.
Speedy HE; Sava G; Houlston RS
Adv Exp Med Biol; 2013; 792():293-308. PubMed ID: 24014302
[TBL] [Abstract][Full Text] [Related]
16. Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia.
Baer C; Dicker F; Kern W; Haferlach T; Haferlach C
Leukemia; 2017 Jun; 31(6):1355-1362. PubMed ID: 27840426
[TBL] [Abstract][Full Text] [Related]
17. Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.
Burger JA; Burger M; Kipps TJ
Blood; 1999 Dec; 94(11):3658-67. PubMed ID: 10572077
[TBL] [Abstract][Full Text] [Related]
18. Translocation t(2;11) in CLL cells results in CXCR4/MAML2 fusion oncogene.
Acunzo M; Romano G; Wernicke D; Balatti V; Rassenti LZ; dell'Aquila M; Kipps TJ; Pekarsky Y; Croce CM
Blood; 2014 Jul; 124(2):259-62. PubMed ID: 24855209
[TBL] [Abstract][Full Text] [Related]
19. Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis.
O'Hayre M; Salanga CL; Kipps TJ; Messmer D; Dorrestein PC; Handel TM
PLoS One; 2010 Jul; 5(7):e11716. PubMed ID: 20661426
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1).
Möhle R; Failenschmid C; Bautz F; Kanz L
Leukemia; 1999 Dec; 13(12):1954-9. PubMed ID: 10602415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
